** Shares in Exosens EXENS.PA rise 8.4% following 'strong'
H1 results, its first earnings report since June IPO, and
confirmed guidance
** The French technology company's H1 revenue rises 50% y/y
to 186.9 million euros ($206.77 million, while adjusted EBITDA
reaches 56.1 million euros
** J.P. Morgan and Bernstein see these H1 results as
"strong"
** "(Exosens) has achieved 50% of our FY24 Adj EBIT forecast
in H1 24 and earnings are often stronger in H2 for defence
companies," JPM says
** JPM adds shares are trading modestly below IPO price due
to underperformance of French stocks during political
uncertainty - it sees these weakness as an entry point
** At 21.20 euros, the shares are about 11.7% below the
opening price of 24 euros on their first day of trading in June
** Out of 5 analysts that cover Exosens SAS, five rate the
stock "strong buy" or "buy"
($1 = 0.9039 euros)
(Reporting by Anna Peverieri)
((Anna.peverieri@thomsonreuters.com))